How are Oral Antibiotics Being Used in Total Joint Arthroplasty? A Review of the Literature.
Travis R WeinerDany B El-NajjarCarl L HerndonCody C WylesH John CooperPublished in: Orthopedic reviews (2024)
While the role and benefit of perioperative intravenous (IV) antibiotics in patients undergoing total joint arthroplasty (TJA) is well-established, oral antibiotic use in TJA remains a controversial topic with wide variations in practice patterns. With this review, we aimed to better educate the orthopedic surgeon on when and how oral antibiotics may be used most effectively in TJA patients, and to identify gaps in the literature that could be clarified with targeted research. Extended oral antibiotic prophylaxis (EOAP) use in high-risk primary, aseptic revision, and exchange TJA for infection may be useful in decreasing periprosthetic joint infection (PJI) rates. When prescribing oral antibiotics either as EOAP or for draining wounds, patient factors, type of surgery, and type of infectious organisms should be considered in order to optimally prevent and treat PJI. It is important to maintain antibiotic stewardship by administering the proper duration, dose, and type of antibiotics and by consulting infectious disease when necessary.
Keyphrases
- patients undergoing
- end stage renal disease
- primary care
- systematic review
- chronic kidney disease
- infectious diseases
- total knee arthroplasty
- minimally invasive
- newly diagnosed
- ejection fraction
- case report
- coronary artery disease
- low dose
- prognostic factors
- acute kidney injury
- total hip
- percutaneous coronary intervention
- robot assisted
- gram negative
- acute coronary syndrome
- atrial fibrillation